Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability Extension of Dexpramipexole in ALS
NCT00931944Phase 2Completed
- Sponsor
- Knopp Biosciences
- Start
- Jul 2009
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexpramipexole in amyotrophic lateral sclerosis (ALS), sponsored by Knopp Biosciences. Started Jul 2009; status: completed.
02
Drugs
dexpramipexole
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00931944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00931944.